---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-099553"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2025-10-16T23:59:59+00:00"
generated_at: "2026-05-17T03:35:53.331078+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Apimeds Pharmaceuticals amends bylaws to allow shareholder action by written consent

## Summary
- Board adopted First Amendment to Bylaws on October 15, 2025, effective immediately.
- Amendment permits shareholders to take action by written consent without a meeting.
- Change provides shareholders an additional mechanism to act outside of annual or special meetings.
- No other changes to the bylaws were made; full amendment filed as Exhibit 3.1.

## SEC filing metadata
- accession: 0001213900-25-099553
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2025-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea0261543-8k_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-099553
- JSON: https://secwatch.observer/filing/0001213900-25-099553.json
- Plain text: https://secwatch.observer/filing/0001213900-25-099553.txt

## Key facts
- Governance Changes
  Apimeds Pharmaceuticals US, Inc.: Bylaws amended to allow shareholder action by written consent (effective 2025-10-15).
  - Change: bylaw amendment
  - Effective: 2025-10-15
  source text: On October 15, 2025, the board of directors of Apimeds Pharmaceuticals US, Inc. (the “Company”) amended the bylaws to allow shareholder action by written consent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.